$XAGE News

Coinbase CEO Brian Armstrong Says His Biotech Company Is Working On 'Extending' Human Lifespan: Here Is How They Plan To Do It

Longevity Health Achieves Top Ratings in CMS Star Quality Measures: A Testament to Excellence in Member Care

12 Health Care Stocks Moving In Friday's Intraday Session

Why Longevity Health Stock Is Skyrocketing Today

12 Health Care Stocks Moving In Tuesday's Intraday Session

Longevity Health shares are trading higher after the company announced it has entered into a definitive merger agreement with True Health.

Longevity Health shares are trading higher after the company announced it has entered into a definitive merger agreement with True Health.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Market-Moving News for July 15th

JPMorgan, Wells Fargo And 3 Stocks To Watch Heading Into Tuesday

Longevity Health Surges 60% After Hours On Merger With THPlasma

Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction

Longevity Health Holdings Announces Rajiv Shukla To Be Executive Chairman; George Chi Appointed As Co-Chairman And CEO, Post Closing

Longevity Health Executes Definitive Merger Agreement With True Health To Combine Companies In All-Stock Transaction; Longevity Announces Mutual Termination Of 20/20 Biolabs Transaction

Longevity Health Merger Agreement Deadline Extended To July 8, 2025; Merger Agreement To Terminate On July 8, 2025 If Not Extended

Longevity Health Extends Strategic Partnership With Humana Through 2030 To Expand Special Needs Medicare Plan Offerings Across Skilled Nursing And Senior Living Facilities, With Plans For Multi-State Growth And Broader Member Reach

Longevity Health extends cash runway into 1Q26

Longevity Health Holdings, Inc. Announces Successful Fundraising Via ATM Sale

Longevity Health Holdings Raises $1.96M Through ATM Equity Offering With Sale Of 479,621 Shares At Average Price Of $4.08 Per Share

Longevity Health Holdings shares are trading higher after the company announced it will retain its Nasdaq listing to complete its merger with 20/20 Biolabs.